Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

3.145 -0.035 (-1.10%)
Streaming Delayed Price Updated: 2:17 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Sensus Healthcare, Inc. - Common Stock

< Previous 1 2 3 Next >
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
Sensus Healthcare Reports Second Quarter 2025 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7
From Sensus Healthcare, Inc.
Via Business Wire
Receipt of MDSAP Certification for Sensus Healthcare’s Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Reports First Quarter 2025 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare to Participate in the 37th Annual ROTH Conference
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Buys Back Shares
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare to Present at The Microcap Conference 2025
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare to Report 2024 Fourth Quarter and Full Year Financial Results and Hold Business Update Conference Call on Wednesday, February 5, 2025
From Sensus Healthcare
Via Business Wire
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration
From Sensus Healthcare, Inc.
Via GlobeNewswire
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Via ACCESSWIRE
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Sells SRT System to Providence Swedish Hospital
Continues customer expansion to hospital oncology departments for the outpatient treatment of non-melanoma skin cancers 
From Sensus Healthcare, Inc.
Via GlobeNewswire
Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024
From Sensus Healthcare, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.